We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

71 hedge funds and large institutions have $522M invested in iKang Healthcare Group, Inc. in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 11

42% more funds holding

Funds holding: 5071 (+21)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

17% more capital invested

Capital invested by funds: $445M → $522M (+$77M)

12% less call options, than puts

Call options by funds: $1.68M | Put options by funds: $1.91M

21% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 19

Holders
71
Holders Change
+21
Holders Change %
+42%
% of All Funds
1.91%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
33
Increased
15
Reduced
19
Closed
11
Calls
$1.68M
Puts
$1.91M
Net Calls
-$229K
Net Calls Change
-$3.62M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$342K -$694K -37,744 -68%
AG
52
Aperio Group
California
$313K +$297K +16,164 New
Renaissance Technologies
53
Renaissance Technologies
New York
$294K -$325K -17,700 -54%
RIM
54
RS Investment Management
California
$290K +$126K +6,877 +85%
Two Sigma Advisers
55
Two Sigma Advisers
New York
$286K +$272K +14,800 New
Geode Capital Management
56
Geode Capital Management
Massachusetts
$274K +$260K +14,172 New
LP
57
LMR Partners
United Kingdom
$246K +$234K +12,742 New
PG
58
PEAK6 Group
Illinois
$244K -$290K -15,805 -56%
BIT
59
BlackRock Institutional Trust
California
$210K +$200K +10,856 New
SG Americas Securities
60
SG Americas Securities
New York
$135K -$459K -24,951 -78%
DSI
61
Daiwa SB Investments
Japan
$93K +$88.2K +4,800 New
UBS Group
62
UBS Group
Switzerland
$71K +$2.35K +128 +4%
Group One Trading
63
Group One Trading
Illinois
$56K +$23.4K +1,275 +80%
Citigroup
64
Citigroup
New York
$33K +$30.7K +1,670 New
Wells Fargo
65
Wells Fargo
California
$32K
Bank of America
66
Bank of America
North Carolina
$20K -$1.17M -63,866 -98%
QT
67
Quantbot Technologies
New York
$5K +$5.51K +300 New
TRCT
68
Tower Research Capital (TRC)
New York
$2K +$1.84K +100 New
Simplex Trading
69
Simplex Trading
Illinois
$1K -$24.6K -1,338 -94%
US Bancorp
70
US Bancorp
Minnesota
$1K +$1.08K +59 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$91 +$86.4K +4,701 New
IG
72
ING Group
Netherlands
-$2.84M -175,229 Closed
TA
73
Teachers Advisors
New York
-$2.63M -161,813 Closed
TCIM
74
TIAA CREF Investment Management
New York
-$1.62M -99,704 Closed
AG
75
AIA Group
Hong Kong
-$1.24M -76,202 Closed

KANG Hedge Fund Activity: Q2 2015 in Review

71 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2015, worth a combined $522M — up 17% from $445M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KANG positions and 11 closed out — a net gain of 22 holders — while 15 added to existing stakes and 19 trimmed.

The largest buyer was Joho Capital, opening a new position worth an estimated $51.9M. The largest seller was Goldman Sachs, cutting an estimated $72.9M.

  • 71 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2015, up from 50 in Q1 2015.
  • Funds reported $522M of iKang Healthcare Group, Inc. stock for Q2 2015, up 17% quarter-over-quarter.
  • 33 funds opened new iKang Healthcare Group, Inc. positions in Q2 2015 and 11 closed out, a net change of +22 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q2 2015 was Joho Capital, an estimated $51.9M added.
  • The largest iKang Healthcare Group, Inc. seller in Q2 2015 was Goldman Sachs, an estimated $72.9M sold.

Based on aggregated 13F filings for Q2 2015.